NCT01294787 - Effect of QVA149 on Exercise Tolerance in Patients With Chronic Obstructive Pulmonary Disease (COPD) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions

COPD

Interventions

DRUG

indacaterol and glycopyrronium bromide (QVA149)

DRUG

placebo

DRUG

tiotropium

Trial Locations (13)

Novartis Investigative Site, Frankfurt

Novartis Investigative Site, Großhansdorf

Novartis Investigative Site, Hamburg

Novartis Investigative Site, Lübeck

Novartis Investigative Site, Mainz

Novartis Investigative Site, Rudersdorf

Novartis Investigative Site, Wiesbaden

Novartis Investigative Site, Alicante

Novartis Investigative Site, Badalona

Novartis Investigative Site, Barakaldo

Novartis Investigative Site, Barcelona

Novartis Investigative Site, Madrid

Novartis Investigative Site, Málaga